{"transactions":[{"id":4623723,"issuer":{"id":9265,"kind":"organization","name":"Electra Therapeutics, Inc.","symbol":"ETRA"},"owners":[{"id":183846,"kind":"person","name":"Koe Gary S.","position":1,"cik":"0002153365","reported_name":"Koe Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-09-21T22:20:09.000Z","date":"2026-09-21","kind":"exercise","planned":false,"acquired":false,"shares":63656,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of  Series A Convertible Preferred Stock (the \"Preferred Stock\") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of  Series A Convertible Preferred Stock (the \"Preferred Stock\") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of  Series A Convertible Preferred Stock (the \"Preferred Stock\") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of  Series A Convertible Preferred Stock (the \"Preferred Stock\") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":63656},"source":{"system":"sec-edgar","filing":"0002153365-26-000004","document":"form4-09212026_100905.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2153365/000215336526000004/form4-09212026_100905.xml","form_type":"4"}},{"id":4623722,"issuer":{"id":9265,"kind":"organization","name":"Electra Therapeutics, Inc.","symbol":"ETRA"},"owners":[{"id":183846,"kind":"person","name":"Koe Gary S.","position":1,"cik":"0002153365","reported_name":"Koe Gary S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-09-21T22:20:09.000Z","date":"2026-09-21","kind":"exercise","planned":false,"acquired":true,"shares":63656,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of  Series A Convertible Preferred Stock (the \"Preferred Stock\") converted automatically into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. Share numbers give effect to such conversion. The Preferred Stock had no expiration date."}],"balance_after":63656,"source":{"system":"sec-edgar","filing":"0002153365-26-000004","document":"form4-09212026_100905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2153365/000215336526000004/form4-09212026_100905.xml","form_type":"4"}}]}